Cell Stress (Mar 2023)

Macrolide antibiotics activate the integrated stress response and promote tumor proliferation

  • Xin Yu,
  • Ai-Ling Tian,
  • Ping Wang,
  • Juanjuan Li,
  • Juan Wu,
  • Bei Li,
  • Zhou Liu,
  • Siqing Liu,
  • Zhijie Gao,
  • Si Sun,
  • Shengrong Sun,
  • Yi Tu,
  • Qi Wu

DOI
https://doi.org/10.15698/cst2023.04.278
Journal volume & issue
Vol. 7, no. 4
pp. 20 – 33

Abstract

Read online

Macrolide antibiotics are widely used antibacterial agents that are associated with autophagy inhibition. This study aimed to investigate the association between macrolide antibi-otics and malignant tumors, as well as the effect on autophagy, reactive oxygen species (ROS) accumulation and integrated stress response (ISR). The meta-analysis indicated a modestly higher risk of cancer in macrolide antibiotic ever-users com-pared to non-users. Further experiments showed that macro-lides block autophagic flux by inhibiting lysosomal acidification. Additionally, azithromycin, a representative macrolide antibi-otic, induced the accumulation of ROS, and stimulated the ISR and the activation of transcription factor EB (TFEB) and TFE3 in a ROS-dependent manner. Finally, animal experiments confirmed that azithromycin promoted tumor progression in vivo, which could be receded by N-acetylcysteine, an inhibitor of ROS and ISR. Overall, this study reveals the potential role of macrolide antibiotics in malignant progression and highlights the need for further investigation into their effects.

Keywords